Healthcare | July 11, 2023
Bausch + Lomb acquires Blink eye drops
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
_256_384.jpeg)
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The audit is a pre-approval inspection for three products filed from the facility
Marksans' OTC Famotidine Tablets USP are acid reducers
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
According to IQVIA sales data for the 12-month period ending December 2022, the Onglyza Tablets, 2.5 mg and 5 mg market achieved annual sales of approximately US $122.3 million
The company has launched its new range of 25 allopathy ophthalmic products including GUERIMOD, GUERIPRED, BIMATO MST etc. for curing various diseases related to eyes
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
